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ABSTRACT 
 Plant calcium (Ca2+) dependent protein 
kinases (CPKs) represent the primary Ca2+-
dependent protein kinase activities in plant 
systems.  CPKs are composed of a dual 
specificity (Ser/Thr and Tyr) kinase domain 
tethered to a Calmodulin-like domain (CLD) via 
an autoinhibitory junction (J).  While regulation 
of CPKs by Ca2+ has been extensively studied, the 
contribution of autophosphorylation in 
controlling CPK activity is less well understood.  
Furthermore, whether Calmodulin (CaM) 
contributes to CPK regulation, as is the case for 
Ca2+/CaM-dependent protein kinases (CaMKs) 
outside the plant lineage, remains an open 
question.  We therefore screened a subset of plant 
CPKs for CaM-binding and found that CPK28 is 
a high-affinity Ca2+/CaM-binding protein.  Using 
synthetic peptides and native gel electrophoresis, 
we coarsely mapped the CaM-binding domain to 
a site within the CPK28 J domain that overlaps 
with the known site of intramolecular interaction 
between the J domain and the CLD.  Peptide 
kinase activity of fully dephosphorylated CPK28 
was Ca2+-responsive and was inhibited by 
Ca2+/CaM.  Using in situ autophosphorylated 
protein, we expand on the known set of CPK28 
autophosphorylation sites, and demonstrate that, 
unexpectedly, autophosphorylated CPK28 had 
enhanced kinase activity at physiological 
concentrations of Ca2+ compared with the 
dephosphorylated protein, suggesting that 
autophosphorylation functions to prime CPK28 
for Ca2+-activation and might also allow CPK28 
to remain active when Ca2+ levels are low.  
Furthermore, CPK28 autophosphorylation 
substantially reduced sensitivity of the kinase to 
Ca2+/CaM inhibition.  Overall, our analyses 
uncover new complexities in the control of 
CPK28 and provide mechanistic support for Ca2+ 
signaling specificity through Ca2+ sensor 
priming. 
 
 
INTRODUCTION 
Adaptation to a dynamic environment is 
necessary for survival and reproduction of all 
organisms.  At the cellular level, environmental 
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stimuli are perceived and coordinated into 
appropriate cellular responses by highly 
interconnected signal transduction networks.  
Following perception by cells, signals are 
transduced to downstream components by a 
variety of mechanisms often including activation 
of second messenger systems such as calcium 
(Ca2+) influxes, or via 
phosphorylation/dephosphorylation cascades 
involving protein kinases and phosphatases, 
respectively.  Indeed, Ca2+ signaling and 
phosphorylation cascades are among the most 
well understood mechanisms of communication 
at the cellular level.  The importance of both Ca2+ 
and protein phosphorylation in plant signal 
transduction is underscored by the considerable 
expansion of protein families involved in these 
processes.  In the model plant Arabidopsis 
thaliana, the protein kinases are represented by 
greater than 1000 members (compared to 
approximately 500 in humans) (1), and more than 
200 proteins with domains implicated in the 
sensing of cytosolic Ca2+ have been identified (2, 
3). 
At the confluence of Ca2+ signaling and 
protein phosphorylation lie the Ca2+-dependent 
protein kinases (abbreviated CPKs in plants and 
CDPKs in protists).  Unique to plants and some 
protists, CPKs are related to metazoan 
Ca2+/calmodulin (CaM)-dependent protein 
kinases (CaMKs) and represent an ancestral 
fusion of a CaMK and CaM (4).  CPKs are 
composed of a variable N-terminal domain 
implicated in substrate binding (5), a dual-
specificity Ser/Thr and Tyr protein kinase domain 
(6), an autoinhibitory junction (J), and a CaM-
like Ca2+-binding domain (CLD) with four or 
fewer conserved EF-hand motifs (7).  
Collectively, the J and CLD form a distinct Ca2+-
sensing domain known as the CDPK activation 
domain (CAD) (8).  At basal cytosolic Ca2+ (~100 
nM), the J domain α-helix extends from the base 
of the kinase domain, resulting in occlusion of the 
catalytic cleft and autoinhibition of the kinase (9–
12).  Under resting conditions, the Ca2+-loaded C-
terminal EF-hand pair of the CAD interacts with 
a short sequence within the J domain, stabilizing 
interaction of the autoinhibitor with the kinase 
domain (13).   Ca2+-dependent activation of CPKs 
is linked to Ca2+-binding by the N-terminal EF-
hand pair of the CAD (12).  Binding of Ca2+ by 
the N-terminal EF-hands leads to dramatic 
conformational rearrangement of the CAD, 
resulting in displacement of the pseudosubstrate 
from the active site and activation of the protein 
kinase (13).  This simple relief of autoinhibition 
model for CPK activation suggests that removal 
of the CAD would be sufficient to generate an 
auto-active kinase domain, and this indeed 
appears to be the case for some plant CPKs (5).  
In contrast, a truncation mutant of CDPK1 from 
Toxoplasma gondii (Tg) lacking its CAD is 
kinase inactive (14), indicating a more complex 
role for the CAD.  Structural studies of TgCDPK1 
reveal an allosteric mechanism where rotation of 
the CAD and its intramolecular interaction with 
the kinase domain stabilizes the active 
conformation of the kinase (13–15).  Further 
analysis of the activation mechanism of plant 
CPKs is required to resolve these conflicting 
observations and to determine whether the 
allosteric activation model is applicable to plant 
CPK isoforms. 
As is typical of Arg-Asp (RD)-type 
protein kinases, CPKs autophosphorylate on Ser 
and Thr residues.  More recently, 
autophosphorylation on Tyr has been 
documented for at least four CPKs (Arabidopsis 
CPK4, CPK28, CPK34 and soybean CDPKβ) (6, 
16).  Although many autophosphorylation sites 
have been identified for CPKs (16, 17), relatively 
little is known about the functional consequences 
of these phosphorylation events.  Limited 
evidence suggests that autophosphorylation 
enhances CPK activity (18, 19), however site-
specific autophosphorylation might also be 
inhibitory (6, 19, 20).  In the case of Tyr 
autophosphorylation, the sole study describing 
functional analysis indicates an inhibitory effect 
of autophosphorylation at a single Tyr site (6).  
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Thus, it is difficult to draw general conclusions 
regarding an overall effect of 
autophosphorylation on CPK activity and it is 
likely that site-specific autophosphorylation will 
affect different properties of CPKs not limited to 
substrate specificity, subcellular localization, and 
Ca2+-binding/sensitivity. 
We are interested in understanding how 
Ca2+, autophosphorylation, and protein-protein 
interactions contribute to regulating CPK 
activity.  In particular, previous studies (21) 
prompted us to explore the possibility that CPKs 
might be regulated by CaM.  In the present study, 
we used recombinant CPKs and a number of 
biochemical approaches to address a possible role 
for CaM in regulation of CPKs and to gain insight 
into how autophosphorylation contributes to CPK 
function.  Our analysis identified CPK28 as a 
novel CaM-regulated protein.  Using an 
Escherichia coli protein expression platform 
enabling differential in situ CPK28 
autophosphorylation, we assessed the effect of 
autophosphorylation on substrate 
phosphorylation using a peptide substrate, and 
expanded on the repertoire of known CPK28 
autophosphorylation sites. Collectively, our 
analyses suggest complex regulation of CPK28 
by Ca2+, autophosphorylation, and CaM-binding. 
RESULTS 
Recombinant Arabidopsis CPK28 is a 
high affinity CaM-binding protein—The rather 
surprising observation that some CPKs can 
interact with CaM (21) prompted us to test 
whether other members of the Arabidopsis CPK 
family could interact with CaM.  Using purified 
recombinant proteins, we tested binding of CaM6 
(a conserved CaM isoform) to a variety of CPKs 
from different sub-groups in Arabidopsis (CPKs 
11, 13, 16, 28, and 34) or soybean (GmCDPKβ).  
Purified recombinant proteins were spotted on 
nitrocellulose membrane along with glutathione-
S-transferase (GST; negative control) and GST-
GmCaMK1, a known CaM-binding protein 
kinase (22), and membranes were probed for 
CaM-binding using horse-radish peroxidase-
labeled CaM (HRP::CaM6).  We chose 200 nM 
as a probe concentration since the large number 
of CaM-binding proteins in vivo necessitates high 
affinity of CaM binding to its targets and 200 nM 
is well within the range of dissociation constants 
described for CaM-binding proteins (23).  Under 
these conditions, we observed binding to GST-
GmCaMK1, His6-CPK28 and to a lesser extent 
His6-CPK16 but no other CPKs or the GST 
negative control (Figure 1).  Importantly, all 
CPKs were active kinases as evidenced by their 
ability to autophosphorylate in situ (Figure 1B), 
indicating that recombinant proteins used in 
binding studies were properly folded.  The 
apparent specific binding of HRP::CaM6 with 
CPK28 identifies CPK28 as a novel CaM-binding 
protein (CaMBP).  We thus characterized the 
CPK28-CaM interaction in further detail. 
 Many CaM-target interactions occur in a 
Ca2+-dependent manner (23) so we tested Ca2+-
dependence of the CaM-CPK28 interaction in 
overlay assays.  Interaction of HRP::CaM6 with 
His6-CPK28 was observed only when spot blots 
were probed in the presence of Ca2+; no binding 
was detected when spot blots were probed in the 
absence of Ca2+ (5 mM EGTA; Figure 2A).  To 
further confirm the specificity of the interaction 
between HRP::CaM6 and His6-CPK28, we 
incubated spot blots with HRP::CaM6 in the 
presence of Ca2+ and an excess of a high affinity 
CaM-binding peptide, W3 (24).  When blots were 
probed under these conditions (Figure 2A) we did 
not observe binding of HRP::CaM6 to His6-
CPK28, indicating that the signal observed in 
spot blot overlay assays in the presence of Ca2+ 
was indeed the result of CaM6 interacting with 
CPK28, rather than non-specific interaction with 
the HRP::CaM6 probe. 
 To confirm overlay results we used CaM-
affinity chromatography as an additional 
approach to test the interaction between CaM and 
CPK28.  We bound His6-CPK28 to CaM-
Sepharose in the presence of saturating (2 mM) 
Ca2+ and eluted bound protein with buffer 
containing 5 mM EGTA.  Fractions were then 
 Regulation of CPK28 by CaM and autophosphorylation 
4 
 
analyzed for the presence of His6-CPK28 by 
immunoblotting with anti-His6 antibodies.  When 
His6-CPK28 was incubated with CaM-Sepharose 
in the presence of Ca2+, we observed a reduction 
of immunoblot signal in the unbound versus the 
input fraction indicating that CaM-Sepharose 
could reduce the amount of His6-CPK28 in 
solution (Figure 2B, upper panel).  Further, we 
observed immunoblot signal in EGTA elution but 
not CaCl2 wash fractions (Figure 2B, upper 
panel), collectively indicating that His6-CPK28 
bound to CaM-Sepharose in a Ca2+-dependent 
manner.  When His6-CPK28 was incubated with 
CaM-Sepharose in the presence of the W3 
peptide, we did not observe a reduction of 
immunoblot signal in unbound versus input lanes, 
nor did we observe immunoblot signal in the 
EGTA elution fractions (Figure 2B, lower panel) 
indicating that His6-CPK28 was specifically 
interacting with immobilized CaM rather than 
non-specifically with the Sepharose support.  
Collectively, spot blot overlay and CaM-affinity 
chromatography experiments indicate that 
CPK28 is a Ca2+-dependent CaM-binding 
protein. 
 The large number of CaM-binding 
proteins in plant cells necessitates high affinity 
binding between CaM and its target proteins.  
Using biolayer interferometry we assessed 
binding of a range of CPK28 concentrations to 
CaM6 immobilized on sensor tips.  Binding of 
CPK28 to immobilized biotinylated-CaM6 
occurred with apparent slow kinetics (Figure 3A).  
Equilibrium binding response (Requilibrium) values 
for each concentration of His6-CPK28 
determined from a 1:1 association binding model 
were used for the steady state Kd calculation 
(Figure 3B).  The calculated Kd of the CPK28-
CaM interaction was 72 ± 14 nM.  Importantly, 
this value falls well within the range of known 
CaM targets indicating that the CPK28-CaM 
interaction could occur under physiological 
conditions.   
To test for in vivo association between 
CPK28 and CaM, we carried out co-
immunopurification (coIP) experiments using 
Arabidopsis plants over-expressing yellow-
fluorescent protein-tagged CPK28 (CPK28-
YFP).  As a control, we used stable transgenics 
expressing the plasma membrane-resident LTI6b 
protein C-terminally tagged with green 
fluorescent protein (LTI6b-GFP) similar to 
previous studies (25, 26).  LC/MS/MS analysis 
indicated that CaM was represented among 
proteins co-immunopurifying with both CPK28-
YFP and the kinase dead D188A variant (27) but 
not in LTI6b-GFP samples (see Supplementary 
Data).  That CaM peptides were identified in coIP 
samples for both the wild-type and D188A 
variants of CPK28 suggests that kinase activity 
may not be required for CaM-binding.  We 
identified two peptides corresponding to residues 
92 to 106 and 107 to 122 of CaM (Table 1).   All 
four conserved CaM isoforms share 100% 
sequence identity within these two peptides and 
thus we are unable to determine whether a 
specific isoform of conserved CaM is interacting 
with CPK28 in vivo.  Nevertheless, our 
experiments establish physiological relevance of 
the CPK28-CaM interaction. 
CaM binds a CPK28 junction domain 
peptide—Using a combination of in silico 
prediction and peptide binding experiments, we 
identified a CaM-binding domain at the C-
terminal end of the CPK28 autoinhibitory 
junction.  This approach was adopted after 
attempts to produce truncated forms of 
recombinant CPK28 proved unsuccessful due to 
susceptibility of truncated proteins to proteolysis 
during expression in E. coli.  We interrogated the 
CPK28 primary sequence for CaM-binding sites 
using the Calmodulin Target Database 
(http://calcium.uhnres.utoronto.ca/ctdb/ctdb/seq
uence.html) and identified a number of putative 
CaM binding domains (CaMBD; Figure 4A).  To 
determine which of these sites interacted with 
CaM, we obtained synthetic peptides 
corresponding to each putative site  and tested 
CaM-binding by native PAGE using the W3 
peptide as a positive control.  We observed an 
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electrophoretic mobility shift of CaM with the 
W3 peptide and the LL22 peptide derived from 
the CPK28 autoinhibitory junction (Figure 4B), 
indicating that the LL22 peptide was bound by 
CaM.  No other peptides derived from CPK28 
induced a similar mobility shift for CaM.  
Furthermore, the mobility shift only occurred in 
the presence of Ca2+ (Figure 4B), confirming 
Ca2+-dependence of the CPK28-CaM interaction.  
In addition to the synthetic peptides tested in 
native PAGE assays, we generated a recombinant 
protein consisting of residues Val276 to Ala328 
of CPK28 spanning the combined region 
represented by the RK21 and FR26 peptides 
derived from the C-terminal end of the kinase 
domain.  This recombinant protein did not 
interact with HRP::CaM6 in overlay assays 
(Figure 4C), and thus we conclude that this region 
does not confer CaM-binding to full length 
CPK28. Modeling of the LL22 peptide (Figure 
4D) indicates that the binding site is amphipathic 
in nature, as is typical for CaMBDs. This region 
is highly conserved among higher plant species 
(Figure 4E) suggesting that CaM-binding might 
have been retained by CPK28 orthologs during 
evolution of the plant CPK lineage.   
The putative binding domain contains 
two bulky hydrophobic residues (Phe344 and 
Phe353) which may serve as anchors for CaM-
binding.  We generated recombinant proteins 
harboring non-conservative F-to-E mutations for 
each of these residues (F344E and F353E) and 
tested their ability to bind CaM in overlay assays.  
The CPK28 F344E mutant was almost 
completely null for HRP::CaM6 binding (Figure 
4F) at a probe concentration of 100 nM, 
suggesting that Phe344 may serve as an anchor 
residue for CaM interaction with CPK28.  By 
comparison, the F353E mutant was unaffected 
with regard to CaM-binding under these 
conditions.  Importantly, loss of binding to the 
CPK28 F344E mutant provides additional 
support for the likely CaM-binding site lying 
within the CPK28 J domain. 
CaM-binding inhibits CPK28 
autophosphorylation and peptide kinase 
activity—To determine the functional 
consequences of CaM binding to CPK28 we 
carried out a series of in vitro kinase assays using 
fully dephosphorylated recombinant CPK28 (see 
‘Experimental Procedures’).  CPK28 
autophosphorylated rapidly in vitro in an ATP-
dependent manner (Figure 5A) and this activity 
was enhanced by the addition of Ca2+ (Figure 
5B).  When CPK28 was autophosphorylated in 
the presence of Ca2+/CaM, we observed a 
reduction in pIMAGO signal (Figure 5B), 
indicating reduced autophosphorylation of the 
kinase.  Similarly, we tested the effect of Ca2+ and 
Ca2+/CaM on activity of CPK28 towards a 
synthetic peptide substrate derived from tomato 
ACC synthase (ACSM+1; NNLRLSMGKR).  
Activity of recombinant CPK28 towards the 
ACSM+1 peptide was strictly Ca2+-dependent as 
indicated by near complete inhibition of peptide 
kinase activity by EGTA (Figure 5C).  In the 
presence of Ca2+/CaM, peptide kinase activity of 
recombinant CPK28 was 43% (95%CI: 38, 47) of 
the Ca2+-stimulated activity (Figure 5C), 
indicating that binding of Ca2+/CaM to CPK28 
resulted in inhibition of CPK28 peptide kinase 
activity.  One simple explanation for the observed 
reduction of CPK28 activity in the presence of 
CaM is competition for Ca2+ between CaM and 
CPK28 in our kinase activity assays.  To rule out 
this possibility we tested the ability of CaM to 
inhibit CPK28 peptide kinase activity in the 
absence or presence of the W3 peptide.  In the 
absence of W3, we observed typical inhibition of 
CPK28 kinase activity as in other experiments 
(Figure 5D).  Importantly, the W3 peptide on its 
own was not inhibitory to CPK28 activity : 
specific activity in the presence of W3 was 7.5 
pmol/min/µg kinase compared to 6.5 
pmol/min/µg kinase in the absence of W3.  By 
comparison, when the W3 peptide was included 
in the kinase assay, Ca2+/CaM inhibition of 
CPK28 activity was abolished (Figure 5D) 
indicating that inclusion of CaM in the kinase 
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reactions is not simply reducing the amount of 
Ca2+ available to CPK28.  Collectively, 
experiments indicate that binding of CaM to the 
CPK28 J domain inhibits both auto- and 
transphosphorylation in vitro thereby establishing 
regulatory function of the Ca2+/CaM-CPK28 
interaction. 
 Additionally, we tested the effect of CaM 
on kinase activity of the CPK28 F344E CaM-
binding mutant of CPK28.  Activity of the wild-
type kinase and the CPK28 F344E mutant 
towards the ACSM+1 peptide was assessed 
across a range of CaM concentrations to estimate 
an IC50 for CaM.  The IC50 for CaM inhibition 
of wildtype CPK28 ranged from 291 to 348 nM.  
By comparison, IC50s for CPK28  F344E ranged 
from 525 to 626 nM (Table 2; Figure 6A and B) 
indicating that the CPK28 F344E mutant is less 
sensitive to CaM compared to the wildtype 
protein.  In addition to reduced CaM sensitivity, 
specific activity of the CPK28 F344E was 
approximately 40% of the wildtype protein 
(Table 2).   
Differential in situ autophosphorylation 
and phosphosite profiling of CPK28—As is the 
case for many Ser/Thr protein kinases, CPKs 
autophosphorylate on Ser and Thr residues and it 
is now recognized that CPKs are capable of Tyr 
autophosphorylation as well (6, 16).   Previously, 
we used in situ autophosphorylated protein to 
generate autophosphorylation profiles for several 
members of the leucine-rich repeat receptor-like 
kinase family (28), and carried out similar 
experiments for CPK28 in the present study.  We 
established expression conditions in E. coli to 
produce differentially autophosphorylated forms 
(‘phosphoforms’) of CPK28.  Recombinant 
CPK28 was produced under three different 
conditions (see Experimental Procedures) and 
autophosphorylation of the different preparations 
was assessed by immunoblotting using the kinase 
dead K91E variant as a control to rule out 
possible activity of endogenous E. coli protein 
kinases (Figure 7).  CPK28 produced during co-
expression with λ protein phosphatase had no 
detectable autophosphorylation whereas protein 
produced without λ protein phosphatase co-
expression had low or high levels of 
autophosphorylation when induction was carried 
out in the absence or presence of 5 mM CaCl2, 
respectively (Figure 7).  We refer to these three 
phosphoforms as P--CPK28 (dephosphorylated), 
P+-CPK28 (low phosphorylation), and P++-
CPK28 (high phosphorylation).  It is noteworthy 
that only P++-CPK28 phosphoform was 
immunoreactive with anti-phosphotyrosine 
antibodies, indicating that elevated [Ca2+]cyt may 
be required for CPK28 to achieve dual 
specificity. 
We subjected the P+- and P++-CPK28 
phosphoforms to trypsin digestion and analysis 
by LC/MS/MS to identify specific sites of 
autophosphorylation (Table 3).  Our analysis 
identified all previously observed CPK28 
autophosphorylation sites with the exception of 
Ser213 in the activation loop as has been 
previously reported (16).  Importantly, our 
experiments confirm autophosphorylation on 
Tyr463 in EF-loop III of the CAD.  In addition to 
known autophosphorylation sites, we identified 
eight novel autophosphorylation sites distributed 
among all subdomains of CPK28. 
Autophosphorylation status affects 
Ca2+responsiveness and CaM-sensitivity of 
CPK28—We assessed the ability of the CPK28 
phosphoforms to phosphorylate the ACSM+1 
peptide substrate under different conditions of 
available Ca2+.  Activity of recombinant CPK28 
phosphoforms was assessed in the presence of 
excess Ca2+ (100 µM CaCl2), the complete 
absence of Ca2+ (500 µM EGTA), or without 
treatment of any kind (untreated, hereafter 
referred to as ‘background Ca2+’).  All three 
CPK28 phosphoforms were sensitive to 
inhibition by EGTA (Figure 8A), indicating strict 
requirement for Ca2+ regardless of 
autophosphorylation status.  P--CPK28 had low 
activity at background Ca2+ and showed 
approximately 6-fold stimulation by excess (100 
µM) Ca2+.  Surprisingly, both the P+- and P++-
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CPK28 phosphoforms had enhanced activity at 
background Ca2+ compared to P--CPK28 (4.5- 
and 3.3-fold enhancement, respectively) and 
neither was substantially stimulated by addition 
of 100 µM CaCl2 (Figure 8A).  Furthermore, both 
P+- and P++-CPK28 displayed a modest reduction 
in maximum activity compared to P--CPK28 
(Figure 8A), indicating that autophosphorylation 
might also have a small inhibitory effect on 
substrate phosphorylation by CPK28 at high 
levels of Ca2+.  To better understand how 
autophosphorylation effects Ca2+-activation of 
CPK28, we assessed peptide kinase activity at 
different concentrations of free Ca2+ spanning 
below and above the physiological range (Figure 
8B).  Both phosphoforms were Ca2+-activated, 
however, P+-CPK28 responded more robustly and 
at lower concentrations of free Ca2+.  Relative to 
kinase activity at 100 nM free Ca2+, activation of 
P--CPK28 could only be detected at 1000 nM free 
Ca2+ (3.5-fold activation).  By comparison, Ca2+ 
activation of P+-CPK28 could be detected at 500 
nM free Ca2+, and was approximately four times 
greater at 1000 nM free Ca2+ (12-fold activation; 
Figure 8B, inset). These results indicate that 
autophosphorylation ‘primes’ CPK28 for Ca2+-
activation. 
We next tested the effect of Ca2+/CaM-
binding on the activity of each phosphoform 
towards the ACSM+1 peptide in the presence of 
Ca2+ (Figure 8C).  As expected, peptide kinase 
activity of P--CPK28 was sensitive to CaM (63% 
inhibition [95%CI: 54, 72]).  In contrast, 
Ca2+/CaM inhibition for P+- and P++-CPK28 was 
18% (95%CI: 9, 27) and 14% (95%CI: 5, 23), 
respectively, indicating that autophosphorylated 
CPK28 was less sensitive to inhibition by 
Ca2+/CaM compared to the dephosphorylated 
protein.  Collectively, our analysis indicates that 
CPK28 autophosphorylation modifies Ca2+-
sensitivity of the kinase and relieves inhibition by 
Ca2+/CaM.  
Because our LC/MS/MS experiments 
identified Ser360 within the putative CPK28 
CaMBD as an autophosphorylation site (Figure 
9A), we hypothesized that autophosphorylation 
might directly inhibit binding of Ca2+/CaM to 
CPK28.  We tested binding of HRP::CaM6 to the 
three CPK28 phosphoforms and to a S360A 
mutant in overlay assays.  We detected reduced 
binding of the HRP::CaM6 probe to P++-CPK28 
compared to P-- and P+-CPK28 (Figure 9B), 
however, the CPK28 S360A mutant did not 
restore binding of the probe to P++-CPK28 
(Figure 9C).  We also tested the effect of 
phosphorylation in native PAGE experiments 
using a modified LL22 peptide phosphorylated at 
Ser360 (pLL22, 
LRQFVRYSRLKQFALRALA[pS]TL; Figure 
9D).  CaM bound the LL22 peptide as indicated 
by reduced mobility of CaM in native PAGE, and 
binding was saturated at a 1:1 molar ratio of 
peptide to CaM (Figure 9D).  CaM also bound the 
pLL22 peptide, however, the proportion of CaM 
with reduced mobility at equimolar CaM and 
peptide was lower relative to unphosphorylated 
LL22 (Figure 9D) indicating reduced binding of 
pLL22 to CaM.  While peptide binding 
experiments are suggestive of inhibition of CaM 
binding by phospho-Ser360, this does not appear 
to hold true for CaM-binding to full-length 
recombinant protein based on overlay assay 
results with the CPK28 S360A mutant.  Thus, we 
tentatively conclude that phospho-Ser360 is not 
the sole phosphosite mediating reduced CaM-
binding to P++-CPK28 and diminished CaM-
sensitivity of peptide kinase activity of the P+- 
and P++-CPK28 phosphoforms. 
DISCUSSION 
Many protein kinases from distinct 
families are among the known repertoire of plant 
CaM-binding proteins (CaMBPs).  Members of 
the receptor-like cytoplasmic kinase (RLCK) 
(22), leucine-rich repeat receptor-like kinase 
(LRR-RLK) (29, 30), CPK-related kinase (CRK) 
(31), and an S-locus receptor kinase (32) are 
CaMBPs, in addition to the well-known Ca2+ and 
Ca2+/CaM-dependent protein kinase (CCaMK) 
involved in bacterial and fungal symbioses (33).  
Besides those protein kinases characterized in 
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detail, a protein array-based screen (21) for CaM 
and CaM-like (CML) binding proteins identified 
an extensive set of protein kinases from multiple 
families, including the CPKs, as putative 
CaMBPs, although the majority of these 
interactions remain to be confirmed by further 
analysis.  The potential for interaction of CaM 
with CPKs prompted us to test a small number of 
recombinant CPKs for CaM-binding.  Previously, 
it was suggested that CPK3, CPK10, and CPK30 
could interact with CaM (21).  In the present 
study, we expand on this set of CaM-binding 
CPKs, identifying CPK28 as a novel CaMBP.  
CPK28 belongs to subgroup IV of the 
Arabidopsis CPKs that includes CPK16 and 
CPK18, with which it shares 82 and 72% 
sequence identity, respectively.  Given the 
relatively high amino acid sequence identity 
between CPK16 and CPK28, it is interesting that 
CPK28 uniquely interacted with CaM in overlay 
assays, and is suggestive of subfunctionalization 
among CPKs.  It is noteworthy that subgroup IV 
of the Arabidopsis CPK family is closely related 
to the CRKs, some of which are CaM-regulated, 
raising the possibility for evolutionary 
conservation of CaM-binding in some but not all 
plant protein kinases descended from eukaryotic 
CaMKs.  Like many other CaMBPs, CPK28 
binds CaM with high affinity and in a Ca2+-
dependent manner.  CPK28 bound CaM with a 
~70 nM Kd, which is well within the range of 
known CaM targets (Kds typically within the 10 
nM to 1 µM range, see ref 23) and the 
physiological levels of CaM.  Furthermore, we 
detected CaM in a complex with CPK28 in co-
immunopurification experiments, and while we 
cannot rule out the possibility that this 
observation is indirect, these experiments support 
the notion that CaM and CPK28 could interact 
under physiological conditions.  Our co-
immunopurification experiments were not able to 
distinguish which specific CaM isoform was 
present in complex with CPK28-YFP due to high 
sequence identity of conserved CaMs.  It seems 
likely that all four conserved Arabidopsis CaM 
isoforms could interact with CPK28 and other 
CaM targets, however, differential expression of 
CaM genes (34) might confer greater specificity 
in binding among CaM and its multitude of 
interacting partners.  
We used an in silico approach to identify 
putative CaM-binding sequences within CPK28.  
This analysis revealed a large number of putative 
binding domains within the CPK28 primary 
structure.  Among synthetic peptides designed 
against these various predicted CaMBDs, only 
one could be demonstrated empirically to interact 
with CaM in vitro.  Predicting CaMBDs is 
complicated by the fact that CaM targets a 
conserved secondary structure for binding rather 
than a primary sequence, and our results suggest 
a high rate of false positive identification of 
CaMBDs in silico.  We suggest that other authors 
interpret CaMBD predictions cautiously, and 
recommend empirical confirmation in vitro 
before experiments in plants are carried out 
where it is difficult to assess the functional 
integrity of mutant proteins that appear not to 
bind CaM.  Delineation of the CPK28 CaMBD 
revealed a binding site within the J domain in a 
position homologous to CaMBDs found in 
animal CaMKs and in plant CRKs.  The CPK28 
CaMBD is highly conserved among land plant 
species, suggesting positive selection for CaM-
binding to CPK28 and its orthologs.  
Interestingly, the putative CPK28 CaMBD 
overlaps with the known site of intramolecular 
interaction between the J and CLD domains of 
CPKs, suggesting the possible requirement for 
conformational rearrangement of CPK28 prior to 
CaM-binding.  This idea is supported by the 
relatively slow association kinetics observed in 
real-time binding assays.  However, further 
structural analysis will be required to test this 
hypothesis.  Analysis of the CPK28 F344E 
mutant which has reduced CaM-binding 
compared to the wild-type protein provides 
additional support for the location of the CPK28 
CaMBD.  That the F353E mutant of CPK28 was 
unaffected with regard to CaM-binding implies 
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that Phe353 is dispensable for formation of the 
CaM-CPK28 complex.  Importantly, the F344E 
mutant was less sensitive to Ca2+/CaM-inhibition 
in kinase assays, but is not a good candidate for 
in vivo functional analysis of the CaM binding to 
CPK28 owing to its reduced specific activity 
compared to the wild-type protein.  Alternative 
approaches will be required to address the 
importance of the CPK28-CaM interaction in 
plants. 
Autophosphorylation has been 
extensively documented for CPKs but 
information is lacking regarding the biochemical 
function and physiological consequences of these 
events.  We manipulated relative 
autophosphorylation levels of CPK28 using 
specific conditions for expression of recombinant 
protein in E. coli and showed that 
autophosphorylation modulates both Ca2+-
activation and Ca2+/CaM sensitivity of the kinase.  
In agreement with a previous study (27), 
chelation of Ca2+ by treatment with EGTA 
inhibited kinase activity indicating a strict 
requirement for bound Ca2+. Addition of Ca2+ to 
100 µM stimulated CPK28 activity compared to 
background Ca2+, however, this was only true for 
the fully dephosphorylated kinase.  Remarkably, 
autophosphorylated CPK28 was almost fully 
active at background Ca2+ in vitro and was no 
longer responsive to added Ca2+.  When we 
analyzed Ca2+-activation of dephosphorylated 
and autophosphorylated CPK28 in more detail, 
we found that autophosphorylated CPK28 
responded more robustly and at a lower 
concentration of free Ca2+ compared to the 
dephosphorylated kinase.  Thus, 
autophosphorylated CPK28 is ‘primed’ for Ca2+-
activation and would be activated by a lower 
threshold of Ca2+ influx in plant cells.  Further, 
activity of autophosphorylated CPK28 might 
decline more slowly relative to dephosphorylated 
kinase during attenuation of Ca2+ signals.  The 
rate of this deactivation phase could be further 
modified by as yet unknown protein phosphatases 
acting on CPK28.  This regulatory mechanism 
could arise from an autophosphorylation-based 
increase in Ca2+-affinity of the CAD or from 
stabilization of the active conformation of the 
protein and current work is aimed at addressing 
this question.  
The role of autophosphorylation in 
control of CPK28 is strikingly similar to 
regulation of human CaMKII by 
autophosphorylation following activation by 
Ca2+/CaM.   Autophosphorylation of Thr286 in 
the CaMKII autoinhibitory domain locks the 
kinase in the activated state by markedly slowing 
dissociation of Ca2+/CaM upon Ca2+ withdrawal, 
ultimately generating a Ca2+-independent enzyme 
(35–37).  CaMKII autophosphorylation thus 
serves as a form of molecular memory allowing 
the kinase to ‘remember’ previous Ca2+ signaling 
events via sustained CaMKII activation after 
autophosphorylation and return to resting 
[Ca2+]cyt.  Our analysis suggests that CPK28 
autophosphorylation may serve a similar 
function, where autophosphorylation during an 
initial Ca2+ signaling event would generate a form 
of the kinase primed for subsequent Ca2+ influx 
events.  Despite these similarities, 
autophosphorylation-based control of CPK28 
must occur via a distinct mechanism owing to 
structural differences between the kinases, and 
the observation that CPK28 does not possess an 
autophosphorylation site directly homologous to 
the regulatory Thr286 site of CaMKII. Our 
observation that autophosphorylation results in 
priming of CPK28 Ca2+-dependent activity 
provides mechanistic support for the Ca2+ 
sensitivity priming model of signaling specificity 
in Ca2+-mediated pathways.  Genetic and Ca2+ 
imaging studies in guard cells reveal that certain 
stimuli (e.g. abscisic acid and CO2) enhance the 
Ca2+-sensitivity of stomatal closing responses, 
indicating that Ca2+-dependent pathways for 
stomatal closure can be primed for activation (38-
41).  It has been suggested that priming is 
regulated by the activity of protein phosphatases 
(41), however, evidence supporting this 
hypothesis is lacking.  We propose that Ca2+ 
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sensor phosphorylation, in particular CPK 
autophosphorylation, might constitute a 
biochemical signature of the primed state of Ca2+-
mediated signaling pathways. . 
From a physiological perspective, 
CPK28 functions to dampen plant immune 
responses in the absence of pathogen attack by 
phosphorylating and contributing to turnover of 
BOTRYTIS-INDUCED KINASE 1 (BIK1) prior 
to pathogen-induced Ca2+ influx (42, 43), a role 
which would require that CPK28 be active at low 
[Ca2+]cyt.  As such, we speculate that site-specific 
CPK28 autophosphorylation will be a critical 
regulatory mechanism for control of plant 
immune homeostasis.  Furthermore, Ca2+-
dependent CaM-binding to CPK28 following rise 
of [Ca2+]cyt during pathogen attack would 
attenuate Ca2+-dependent activation of CPK28,   
reducing BIK1 turnover and enhancing BIK1-
mediated immune signaling.  Alternatively, 
CaM-binding to autophosphorylated CPK28 
could block further autophosphorylation at 
specific sites or shield specific sites from the 
activity of protein phosphatases, functioning as a 
mediator of autophosphorylation-based control of 
CPK28.  Understanding how 
autophosphorylation and CaM-binding control 
CPK28 activity in planta will require studies 
detailing spatio-temporal properties of CPK28 
autophosphorylation in vivo and are outside the 
scope of the present study. 
In conclusion, our analysis of 
recombinant CPK28 reveals previously unknown 
mechanisms regulating kinase activity: 
Ca2+/CaM binding and modulation of Ca2+-
sensitivity by autophosphorylation.  Importantly, 
regulation of CPK28 by CaM-binding and 
autophosphorylation  fit well into current models 
of the physiological role of CPK28 in controlling 
plant immune homeostasis.  It will be interesting 
in the future to see whether autophosphorylation 
similarly controls other members of the CPK 
family and how both Ca2+/CaM-binding and 
autophosphorylation contribute to regulation of 
CPK28 in plants. 
EXPERIMENTAL PROCEDURES 
Cloning and constructs—Clones for 
CPK11, CPK13, and CPK16 were obtained from 
the Arabidopsis Biological Resource Center.  The 
CPK28 cDNA was amplified from a cDNA pool 
derived from Arabidopsis ecotype Col-0 leaf 
tissue.  Oligonucleotide primers used for 
amplification are listed in Table 4.  PCR product 
was digested with appropriate restriction 
enzymes, gel purified and ligated into digested 
pET28a(+) for in frame fusion with an N-terminal 
His6 tag.  Clones were isolated and confirmed by 
DNA sequencing and in silico translation.  
Confirmed clones were transformed into different 
host strains for recombinant protein expression as 
described below. 
 Site-directed mutagenesis of the 
pET28a(+):CPK28 expression clone was carried 
out using procedures exactly as previously 
described (44).  Oligonucleotide primers used for 
site-directed mutagenesis are listed in Table 4.  
All mutagenized clones were confirmed by DNA 
sequencing and in silico translation prior to 
transformation into protein expression hosts for 
production of recombinant protein. 
Recombinant protein expression and 
purification—Recombinant CPK28 and site-
directed mutants were expressed as N-terminal 
His6-tagged fusion proteins in E. coli under 
various conditions as described below.  
Expression cultures consisting of Luria broth 
(LB) containing 50 µg/ml kanamycin were 
inoculated with 1:100 volume of saturated starter 
culture and were incubated with shaking at 37°C 
until the culture reached an optical density of 
approximately 0.6 at 600 nm.  Production of His6-
CPK28 was induced by adding isopropyl β-D-1-
thiogalactopyranoside (IPTG) to a final 
concentration of 0.5 mM, and expression was 
allowed to proceed for 16 h at room temperature.  
To obtain dephosphorylated His6-CPK28 (P--
CPK28), expression was carried out in the E. coli 
BL21(DE3)-VR2-pACYC-LamP host strain that 
co-expresses λ protein phosphatase (13).  Hyper- 
and hypo-phosphorylated His6-CPK28 (P++-
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CPK28 and P+-CPK28) were obtained by 
expression in T7 Express LysY/Iq with or without 
the addition of 5 mM CaCl2 to the culture at the 
time of induction, respectively.  Cells from 500 
ml of culture were pelleted at 3,500 xg for 10 min 
and were suspended in 25 ml of cell extraction 
buffer (50 mM Tris-HCl, pH 7.5 containing 0.5 
mM AEBSF, 10 µM leupeptin, 1 mM 
benzamidine hydrochloride, 2 mM ε-amino-
caproic acid, and 0.5 µM E-64, 10 mM NaF, 1 
mM Na3VO4, and 1 mM Na2MoO4).  Cells were 
lysed by treatment with 250 µg/ml lysozyme at 
room temperature for 20 min followed by one 
freeze-thaw cycle and treatment with 125 U of 
benzonase nuclease (EMD Millipore) to reduce 
viscosity.  Additional sonication (four 10 s cycles 
with 10 s rests) was used for lysis of the 
BL21(DE3)-VR2-pACYC-LamP host.  Lysates 
were clarified by centrifugation at 35,000 x g for 
30 min.  Crude lysates were adjusted to 300 mM 
NaCl and 50 mM imidazole followed by gravity-
flow purification with Ni-NTA (Qiagen) exactly 
as previously described (23).  Elution fractions 
were pooled, concentrated, and dialyzed against 
three changes of 1000 volumes of 25 mM Tris-
HCl pH 7.5, 100 mM NaCl, 1 mM dithiothreitol 
(DTT).  Protein concentration was typically 
determined by Bradford assay using bovine 
serum albumin as standard or by absorbance at 
276 nm in 6 M guanidine HCl using a calculated 
extinction coefficient of 50,880 M-1∙cm-1 (for 
determination of binding kinetics).  Purity was 
assessed by SDS-PAGE and staining with 
Coomassie Brilliant Blue G250 protein stain 
(Sigma Aldrich).  Aliquots of protein were stored 
at -80°C until use, or were used immediately for 
determination of binding kinetics. 
 Recombinant CaM6 (untagged) was 
expressed in the E. coli NiCO (DE3) (New 
England Biolabs) host strain.  Cultures (LB 
containing 50 µg/ml ampicillin) were inoculated 
as described above and were grown at 37°C to an 
optical density of approximately 0.6 at 600 nm.  
Protein production was induced by the addition of 
0.5 mM IPTG, and expression was allowed to 
proceed for 4 h at 37°C.  Cells from 100 ml of 
culture were suspended in 10 ml of cell extraction 
buffer as described above but lacking NaF, 
Na3VO4 and Na2MoO4.  Cells were lysed by 
treatment with 250 µg/ml lysozyme for 20 min at 
room temperature followed by a single freeze-
thaw cycle and sonication (see above).  Debris 
was pelleted at 35,000 x g for 30 min.  CaCl2 was 
added to the clarified lysate to a final 
concentration of 5 mM and the lysate was heated 
to 90°C for 3 min.  Precipitated E. coli proteins 
were removed by centrifugation for 20 min at 
35,000 x g.  Recombinant CaM6 was purified as 
described (45) by Ca2+-dependent hydrophobic 
interaction chromatography (HIC) using phenyl-
Sepharose (GE Lifesciences) chromatography 
resin. 
SDS-PAGE and immunoblotting—For 
SDS-PAGE, proteins were diluted in with 4X 
NuPAGE loading buffer (Life Technologies) to a 
final loading buffer concentration of 1X.  SDS-
PAGE samples additionally contained 100 mM 
DTT as reductant.  Proteins were separated in 
10% (v/v) acrylamide Bis-Tris-HCl (pH 6.8) 
NuPAGE gels.  For immunoblotting experiments, 
proteins were transferred to polyvinyidene 
fluoride (PVDF) membrane.  Membranes were 
washed with phosphate-buffered saline (8 mM 
sodium phosphate, 2 mM potassium phosphate, 
137 mM NaCl, 2.7 mM KCl) containing 0.1% 
(v/v) Tween-20 (PBS-T) and then blocked for 1 h 
to overnight at room temperature in PBS-T 
containing 5% (w/v) cold water fish skin gelatin 
(Sigma-Aldrich).  After blocking, membranes 
were rinsed in PBS-T and were then incubated 
with appropriate primary antibodies as follows: 
anti-His6 (Sigma-Aldrich product # H1029, lot # 
013M4866), 1:3,000, overnight incubation at 
room temperature; anti-phosphothreonine (anti-
pThr; Sigma Aldrich product # SAB5200089, lot 
# 131122), 1:500, 2 h incubation at room 
temperature; anti-phosphotyrosine (anti-
pY4G10, Millipore product # 05-1050, lot # 
2475690), 1:1,000, overnight at 4°C.  After 
primary antibody binding, membranes were 
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washed three times for 5 min each in PBS-T and 
were then incubated for 1 h at room temperature 
in either goat anti-rabbit-HRP (Thermo Fisher 
Scientific, product # 31462, lot number 
unavailable) or goat anti-mouse-HRP (Thermo 
Fisher Scientific, product # 31432, lot # 
PE1855475) as appropriate at a dilution of 1:20 
000 in PBS-T containing 1% (w/v) cold water 
fish skin gelatin (Sigma-Aldrich).  Membranes 
were washed as above and then rinsed with PBS 
to remove excess detergent.  Blots were then 
incubated in Pierce ECL Western Blotting 
Substrate (Thermo Fisher Scientific) following 
manufacturer’s instructions and 
chemiluminescent signals were captured using a 
c-Digit blot scanner (Li-Cor Biosciences).  For 
detection of total phosphorylation of recombinant 
proteins, blotting with the pIMAGO reagent 
(Tymora Analytical) was carried out exactly 
according to manufacturer’s instructions except 
that iodoacetamide was not added to SDS-PAGE 
samples of purified recombinant proteins.  
pIMAGO blots were imaged using the Pierce 
ECL Western Blotting Substrate and the c-Digit 
blot scanner. 
Generation of HRP::CaM6 and spot blot 
overlay assays—Purified recombinant CaM6 was 
reduced at 55°C for 1 h with 100 mM DTT 
followed by dialysis against three changes of 
1000 volumes of degassed PBS.  Reduced CaM6 
was combined with maleimide-activated horse-
radish peroxidase (HRP; Thermo Fisher 
Scientific) at a 1:1 molar ratio and the labeling 
reaction was carried out for 6 h at room 
temperature.  Labeled HRP::CaM6 was purified 
by Ca2+-dependent HIC to remove unreacted 
HRP and the purified probe was assessed by 
SDS-PAGE.  To generate biotinylated CaM6 for 
Octet assays, 1 mg of purified CaM6 (1 mg/ml 
concentration) was incubated with 1.2 mmol 
Biotin-PEG2-maleimide (Thermo Fisher 
Scientific) overnight.  Excess labeling reagent 
was removed by dialysis against 1000 volumes of 
25 mM Tris-HCl, pH 7.5.  Aliquots of 
HRP::CaM6 and Biotin-PEG2-CaM6 were stored 
at -80°C until use. 
 HRP::CaM6 spot blot assays were 
carried out by spotting purified recombinant 
proteins as indicated to nitrocellulose.  The 
amount of protein spotted was typically 0.5 µg 
unless otherwise indicated.  Spots were dried and 
membranes were stained with Ponceau S to 
confirm equal loading of proteins.  Membranes 
were rinsed briefly with 20 ml of Tris-buffered 
saline (TBS, 25 mM Tris-HCl pH 7.5, 140 mM 
NaCl, 2.5 mM KCl) containing 2 mM CaCl2 
(TBS-C) to remove the Ponceau stain, and were 
then blocked in the same buffer with 5% (w/v) 
skim milk powder for 1 h at room temperature.  
Membranes were rinsed briefly with TBS-C to 
remove excess milk and were then probed with 
200 nM HRP::CaM6 in TBS-C containing 1% 
(w/v) skim milk powder for 1 h at room 
temperature.  Spot blots were washed three times 
for 10 min each in TBS-C.  After washing, 
membranes were incubated in Pierce ECL 
Western Blotting Substrate following 
manufacturer’s instructions.  Hyblot CL 
autoradiography film (Denville Scientific) was 
exposed to membranes for 5 to 20 s and then 
developed in a Kodak M35A X-OMAT 
processor.  Under these conditions, interaction of 
HRP::CaM6 with CPK28 and the positive control 
could be routinely detected with 5 s film 
exposures.  Developed films were digitized using 
a CanoScan 4400F flatbed scanner (Canon).  All 
His6-CPK28 samples for binding experiments 
were expressed under conditions giving P+-
CPK28 as described above unless otherwise 
indicated. 
Immobilized CaM chromatography— 
CaM-Sepharose (GE Lifesciences) binding 
experiments were carried out in 50 mM Tris-HCl, 
pH 7.5 containing 2 mM CaCl2 and 1 mM DTT 
(binding buffer).  20 µg of His6-CPK28 in 
binding buffer (1 ml final sample volume) was 
incubated with 40 µl of resin (40 µg binding 
capacity) for 1 h at room temperature in a 
microcentrifuge tube on a rotator.  After binding, 
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resin was pelleted for 5 min at 2,400 x g.  Resin 
was washed three times with 1 ml binding buffer, 
followed by three elutions (80 µl each) with 50 
mM Tris-HCl, pH 7.5, 5 mM EGTA.  Equal 
volumes of each fraction (input, unbound, 
washes, and elutions) were separated by SDS-
PAGE and transferred to PVDF for 
immunoblotting with anti-His6 antibodies as 
described above.   
Real-time protein-protein interactions 
assays in the Octet system—Quantitative analysis 
of the CaM6-CPK28 interaction was carried out 
using biolayer interferometry in the Octet system 
(Forte Bio).  Biotinylated CaM6 (10 µg/ml) 
prepared as described above was immobilized for 
30 s on streptavidin biosensors.  After 
immobilization, signal baseline was determined 
in TBS-C for 100 s before incubating CaM6-
labeled biosensors in different concentrations of 
purified recombinant His6-CPK28 prepared as a 
serial dilution in TBS-C from a 10 µM stock 
solution.  Association and dissociation steps were 
carried out for 1,800 s in TBS-C.  Binding 
experiments were carried out at 30°C and 1,000 
rpm shaking. 
 Raw binding traces were buffer 
subtracted and aligned to the baseline reading for 
individual sensors.  Using the association step 
only, equilibrium binding (Requilibrium) was 
determined for each concentration of His6-
CPK28 by fitting binding traces to a 1:1 binding 
model in the Octet data analysis software.  
Requilibrium values were plotted against 
concentration and Kd was determined using a 
steady-state binding model: 𝑅𝑅𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 =
𝑅𝑅𝑒𝑒𝑚𝑚𝑚𝑚 ( [𝐶𝐶𝐶𝐶𝐶𝐶28][𝐶𝐶𝐶𝐶𝐶𝐶28]+𝐶𝐶𝑑𝑑) 
Initial values for Rmax and KD were estimated at 5 
and 100 nM, respectively.  Steady-state curve 
fitting and Kd determination was carried out in 
OriginPro 2015 (OriginLab Corporation). 
Immunoprecipitation of CPK28-YFP and 
detection of associated proteins by LC/MS/MS—
Creation of stable transgenic complementing 
cpk28-1/35S::CPK28-YFP and non-
complementing cpk28-1/35S::CPK28-D188A-
YFP lines was previously described (27).  Control 
Col-0/LTI6b-GFP lines were also previously 
described (25, 26).  Immunoprecipitation of 
LTI6b-GFP, CPK28-YFP, or CPK28-D188A-
YFP was performed as described in (42) using 
anti-GFP µMACS magnetic beads (Miltenyi 
Biotec).  Proteins were eluted in pre-warmed 
SDS-PAGE loading buffer per the 
manufacturer’s instructions and subjected to 
SDS-PAGE.  Protein samples were prepared for 
MS analysis by excising bands from SDS-PAGE 
gels stained in Coomassie Brilliant Blue (Simply 
Blue ™ Safe stain, Invitrogen). Gel slices were 
destained in 50% acetonitrile and incubated for 
45 min in 10 mM DTT. Cysteinyl residue 
alkylation was performed for 30 min in the dark 
in 55 mM chloroacetamide. After several washes 
with 25 mM ammonium bicarbonate 50% 
acetonitrile gel slices were dehydrated in 100% 
acetointrile. Gel pieces were rehydrated with 50 
mM ammonium bicarbonate and 5% acetonitile 
containing 20 ng/µl trypsin (Pierce) and digestion 
proceeded overnight at 37ºC.  Tryptic peptides 
were sonicated from the gel in 5% formic 
acid/50% acetonitrile and the total extracts 
evaporated until dry. 
LC/MS/MS analysis was performed 
using a Orbitrap Fusion trihybrid mass 
spectrometer (Thermo Scientific) and a 
nanoflow-UHPLC system (Dionex 
Ultimate3000, Thermo Scientific). Peptides were 
trapped to a reverse phase trap column (Acclaim 
PepMap C18, 5 µm, 100 µm x 2 cm, Thermo 
Scientific) connected to an analytical column 
(Acclaim PepMan 100, C18 3 µm, 75 µm x 50 
cm, Thermo Scientific). Peptides were eluted in a 
gradient of 3-30 % acetonitrile in 0.1 % formic  
acid (solvent B) over 50 min followed by gradient 
of 30-80 % B over 6 min at a flow rate of 300 
nL/min at 40°C. The mass spectrometer was 
operated in positive ion mode with nano-
electrospray ion source with ID 0.02mm fused 
silica emitter (New Objective). Voltage +2200 V 
was applied via platinum wire held in PEEK T-
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shaped coupling union with transfer capillary 
temperature set to 275ºC. The Orbitrap, MS scan 
resolution of 120,000 at 400 m/z, range 300 to 
1800 m/z was used, and automatic gain control 
(AGC) was set to 2×105 and maximum inject time 
to 50 ms. In the linear ion trap, product ion 
spectra were triggered with a data-dependent 
acquisition method using ‘top speed’ and ‘most 
intense ion’ settings. The threshold for collision 
induced dissociation (CID) and high energy 
collisional dissociation (HCD) was set using the 
Universal Method (above 100 counts, rapid scan 
rate, and maximum inject time to 10 ms). The 
selected precursor ions were fragmented 
sequentially in both the ion trap using CID and in 
the HCD cell. Dynamic exclusion was set to 30 s. 
Charge state allowed between +2 and +7 charge 
states to be selected for MS/MS fragmentation. 
Peak lists in format of Mascot generic 
files (.mgf files) were prepared from raw data 
using MSConvert package (Matrix Science). 
Peak lists were searched on Mascot server v.2.4.1 
(Matrix Science) against TAIR (version 10) 
database, a separate in-house constructs database 
and an in-house contaminants database. Tryptic 
peptides with up to 2 possible mis-cleavages and 
charge states +2, +3, +4, were allowed in the 
search. The following modifications were 
included in the search: oxidized Met, 
phosphorylation on Ser, Thr, Tyr as variable 
modifications and carbamidomethylated Cys as a 
static modification. Data were searched with a 
monoisotopic precursor and fragment ions mass 
tolerance 10 ppm and 0.6 Da, respectively. 
Mascot results were combined in Scaffold v. 4 
(Proteome Software) and exported to Excel 
(Microsoft Office). 
Peptide binding and Non-denaturing 
PAGE—Synthetic peptides were obtained from 
LifeTein (New Jersey, USA) (Table 5).  
Lyophilized peptides were dissolved in sterile 
water to a concentration of 1 mg/ml and stored at 
-20°C until use.  Analysis of peptide binding was 
carried out following the method described by 
Azari et al. (46). Briefly, 240 pmol CaM was 
incubated with an equal amount of synthetic 
peptide as indicated in 25 mM Tris-HCl, pH 7.5 
containing either 100 µM CaCl2 or 2 mM EGTA.  
Final reaction volumes were 20 µl.  Reactions 
were incubated at room temperature for 60 min 
after which, 12.5 µl of loading buffer was added.  
Twenty microliters of the sample was then loaded 
into 12.5 % (v/v) acrylamide nondenaturing Tris-
glycine gels containing either 100 µM CaCl2 or 2 
mM EGTA and samples were separated at 25 mA 
constant for 90 min.  Following electrophoresis, 
gels were stained with GelCode Blue protein 
stain. 
CPK28 autophosphorylation and peptide 
kinase assays—Autophosphorylation assays were 
carried out using in situ dephosphorylated His6-
CPK28.  For time course assays, 20 µg His6-
CPK28 was incubated in a 200 µl reaction 
containing 25 mM Tris-HCl, pH 7.5, 10 mM 
MgCl2, 100 µM CaCl2, 1 mM DTT.  Reactions 
were initiated by the addition of 100 µM ATP and 
20 µl of the reaction was withdrawn and stopped 
by addition to 20 µl 2X SDS-PAGE loading 
buffer and heating at 65°C for 1 minute at each 
time point as indicated.  To assess the effect of 
Ca2+ and Ca2+/CaM on CPK28 
autophosphorylation, reactions were carried out 
as above but with or without 100 µM CaCl2 and 
with or without 2 µM CaM6 as indicated.  
Reactions were incubated for 30 min prior to 
initiation with 100 µM ATP to allow formation of 
the CPK28-CaM complex. Final reaction 
volumes were 50 µl and contained 5 µg of His6-
CPK28.  Reactions proceeded for 30 s and were 
stopped by the addition of 50 µl of 2X SDS-
PAGE loading buffer and heating at 65°C for 1 
min.  Autophosphorylation reactions were 
assessed by immunoblotting with anti-pThr and 
pIMAGO as described above.   
Peptide kinase assays were carried out as 
previously described (40).  Briefly, assays 
contained 40 mM Tris-HCl pH 7.5, 1 mM DTT, 
10 mM MgCl2, 100 µM ATP, 0.1 µCi/µl γ32P-
ATP (150 cpm/pmol), 0.5 µg of His6-CPK28, and 
10 µM ACSM+1 peptide substrate (sequence: 
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NNLRLSMGKR).  Reactions were initiated by 
addition of an ATP/γ32P-ATP mixture.  
Additionally, reactions contained combinations 
of 100 µM CaCl2, 0.5 mM EGTA, 1 µM CaM6 
or 2 µM W3 peptide as indicated in the 
appropriate figures.  Final reaction volumes were 
40 µl.  For CaM inhibition experiments, reactions 
were incubated for 30 min at room temperature 
prior to addition of ATP.  After addition of ATP, 
reactions were allowed to proceed for 10 min at 
room temperature and were stopped by spotting 
35 µl of each reaction onto P81 phosphocellulose 
cation exchange paper followed by washing three 
times for 5 min each in 0.45% (v/v) o-phosphoric 
acid.  Incorporation of 32P was assessed by liquid 
scintillation counting. 
Identification of in situ CPK28 
autophosphorylation sites by LC/MS/MS—
Purified recombinant P+-CPK28 and P++-CPK28 
were electrophoresed in 10% acrylamide Bis-Tris 
gels.  Gels were fixed in methanol:acetic 
acid:water (50:7:43), rinsed three times for 10 
min each with  distilled H2O and stained with Gel 
Code Blue protein stain (Thermo Fisher 
Scientific).  Protein bands corresponding to 
CPK28 were excised and minced, and gel pieces 
were washed with acetonitrile:100 mM 
ammonium bicarbonate pH 8.0 (1:1, v:v) 
followed by three cycles of shrinking/swelling 
with acetonitrile and 100 mM ammonium 
bicarbonate, respectively.  Gel pieces were 
reduced with fresh-made 10 mM DTT for 30 min 
at 37°C followed by alkylation with 55 mM 
iodoacetamide for 20 min at room temperature.  
Gel pieces were subjected to three cycles of 
shrinking/swelling with acetonitrile and 50 mM 
ammonium bicarbonate, respectively.  The last 
swelling step included trypsin (Promega Trysin 
Gold, Mass Spectrometry grade, catalog # 
V5280, lot # 0000146430) at a concentration of 
10 ng/µl.  In-gel trypsin digestions were carried 
out at 37°C overnight.  
 CPK28 peptide samples were dried under 
vaccuum and resuspended in 20 µl of 1% acetic 
acid.  Each sample (5 µl each) was subjected to 
analysis by nanoUPLC using an Easy nanoLC 
1000 system (Thermo Fisher Scientific) coupled 
to an Orbitrap Elite mass spectrometer (Thermo 
Fisher Scientific).  Peptides were separated using 
a linear gradient from 5% B to 40% B over 60 
min (A=0.1% formic acid, 2% acetonitrile in 
water; B=0.1% formic acid in acetonitrile) over a 
75 μm id x 20 cm Picofrit self-pack column (New 
Objective) packed with 3 μm Magic C18 
(Michrom Bioresources) at a flow rate of 300 
nl/min.  Two sets of data-dependent mass 
spectrometry data were collected.  First, all 
samples were analyzed using a top 5 HCD 
(higher-energy collisional dissocation) 
methodology.  In a second experiment, samples 
were subjected to a data-dependent methodology 
utilizing both HCD and ETD (electron transfer 
dissociation) in a charge state and mass-to-charge 
dependent manner.    All +2 charge ions were 
subjected to HCD, as were +3 ions > m/z 650, +4 
ions > m/z 900, and +5 ions > m/z 950.  All other 
ions were subjected to ETD with a 100 ms 
activation time with supplemental HCD 
activation enabled.  Raw data files were 
processed using Proteome Discoverer 1.4, and 
resulting product ion spectra were searched 
against the TAIR10 database using Mascot 2.5 
with the following parameters:  precursor and 
product ion mass tolerance-10ppm; trypsin 
specificity with up to 1 missed cleavage site; 
carbamidomethyl-Cys as a fixed modification; 
phospho-Ser, phospho-Thr, phospho-Tyr, and 
Met oxidation as variable modifications.  
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Table 1. Calmodulin peptides identified in CPK28-YFP co-immunopurification experiments. 
Peptidea Sampleb Mr(expt) Delta (ppm) 
Peptide ID 
probability (%) 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 2.5 97.3 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 1.3 99.7 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 1.3 99.7 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 2.5 99.7 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 0.9 99.7 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 0.9 95.9 
R.VFDKDQNGFISAAELR.H CPK28-YFP 1808.91 0.9 99.7 
K.(ox)MKDTDSEEELKEAFR.V CPK28D188A-YFP 1842.83 1.3 98.9 
K.(ox)MKDTDSEEELKEAFR.V CPK28D188A-YFP 1842.83 0.3 99.0 
K.(ox)MKDTDSEEELKEAFR.V CPK28D188A-YFP 1842.83 0.3 99.0 
K.(ox)MKDTDSEEELKEAFR.V CPK28D188A-YFP 1842.83 1.3 99.7 
R.VFDKDQNGFISAAELR.H CPK28D188A-YFP 1808.91 2.1 99.7 
R.VFDKDQNGFISAAELR.H CPK28D188A-YFP 1808.91 1.9 99.7 
R.VFDKDQNGFISAAELR.H CPK28D188A-YFP 1808.91 1.9 99.7 
a, (ox)M represents oxidized methionine; b, overexpression of CPK28-YFP or CPK28D188A-YFP in the cpk28-1 knockout 
background. 
 
 
Table 2. Kinase activity comparison of recombinant CPK28 and the F344E CaM-binding mutant 
 CPK28 F344E 
Specific Activity 
(pmol∙min-1∙ug-1 kinase)a,b 9.3 ± 1.5 4.0 ± 1.2 
CaM Sensitivity   
Replicate #1   
IC50 (nM) 291 ± 39 575 ± 86 
Adjusted R2 0.952 0.940 
Replicate #2   
IC50 (nM) 348 ± 84 525 ± 82 
Adjusted R2 0.909 0.941 
Replicate #3   
IC50 (nM) 327 ± 41 626 ± 61 
Adjusted R2 0.951 0.962 
a, assessed using 0.5 µg kinase, 100 µM ATP, and 10 µM ACSM+1 peptide in the presence of 100 µM 
CaCl2; b, mean with 95% CI 
 
Table 3. Phosphopeptides identified from in situ autophosphorylated recombinant CPK28a. 
Siteb Mr(expt) Mr(calc) E-value Peptide Fragmentation Reference 
Ser6 988.4201 988.4202 0.0041 M.GVCFpSAIR.V HCD - 
Ser24 1207.5859 1207.5849 4.2e-07 K.pSKAAPTPIDTK.A HCD 16 
Thr33 1379.6712 1379.6697 0.00032 K.AAPTPIDpTKASTK.R HCD 16 
Ser36 1379.6718 1379.6697 0.00095 K.AAPTPIDTKApSTK.R HCD 16 
Thr33/Thr37 1615.7376 1615.7372 0.00043 K.AAPTPIDpTKASpTK.R ETD - 
Ser43 898.3620 898.3620 0.0014 R.TGpSIPCGK.R HCD 16 
Ser198 1037.4808 1037.4794 1.0e-05 K.pSAQLDSPLK.A HCD - 
Ser228 1986.9549 1986.9492 5.1e-10 R.FHDIVGpSAYYVAPEVLK.R HCD 16, 17, 27 
Ser318 1502.7392 1502.7395 6.0e-05 R.LTAAQALpSHAWR.E HCD 16, 17, 27 
Thr329 2075.9707 2075.9888 0.0016 R.EGGNApTDIPVDISVLNNLR.Q HCD - 
Ser360 1682.7788 1682.7764 9.5e-09 R.ALApSTLDEAEISDLR.D HCD - 
Tyr463† 1271.5453 1271.5435 0.0036 K.DGpYITPEELR.M HCD 16 
Ser478 1607.7088 1607.7080 3.9e-06 R.GpSIDPLLDEADIDR.D HCD - 
Ser495 1280.5914 1280.5914 0.00058 R.DGKIpSLHEFR.R HCD 17, 27 
Ser510 928.4015 928.4015 0.0002 R.TASISpSQR.A HCD - 
Ser510 1701.7954 1701.7948 3.0e-10 R.TASISpSQRAPSPAGHR.N ETD - 
Ser507/Ser510 1008.3676 1008.3678 0.039 R.TApSISpSQR.A HCD - 
Ser507/Ser510 1781.7618 1781.7611 0.00013 R.TApSISpSQRAPSPAGHR.N ETD - 
a, data shown are from representative peptide identifications, all product ion spectra were inspected manually to ensure correct phosphosite 
identification; b, sites listed in bold are new sites identified only in the present study; †pTyr463 was only identified in samples from protein 
expressed with the addition of CaCl2 to the expression culture at the time of induction.   
 
Table 4. Oligonucleotide primers used in this study. 
Name Restriction 
site 
Sequencea Purpose 
CPK28_F_NdeI NdeI atcgcatatgGGTGTCTGTTTCTCCGCC pET28a cloning 
CPK28_R_NotI NotI atcggcggccgcCTATCGAAGATTCCTGTGACC pET28a cloning 
CPK11_F_NdeI NdeI atcgcatatgGAGACGAAGCCAAACCCTAGACG pET28a cloning 
CPK11_R_NotI NotI atcggcggccgcTCAGTCATCAGATTTTTCACC pET28a cloning 
CPK13_F_NdeI NdeI atcgcatatgGGAAACTGTTGCAGATCTCCCGC pET28a cloning 
CPK13_R_NotI NotI atcggcggccgcCTATTCGTTGCCTAGGTTC pET28a cloning 
CPK16_F_NheI NheI atcggcatgcATGGGTCTCTGTTTCTCCTCC pET28a cloning 
CPK16_R_NotI NotI atcggcggccgcTTAGACCTTGCGAGAAATAAGATAACC pET28a cloning 
    
S360A - CAATTTGCTTTAAGGGCGCTTGCTgcCACACTTGACGAGGCAGAGATCTC CPK28 mutagenesis 
S360Arc - GAGATCTCTGCCTCGTCAAGTGTGgcAGCAAGCGCCCTTAAAGCAAATTG CPK28 mutagenesis 
F344E - CATTTCAGTTCTGAACAACTTAAGACAAgaaGTGAGATACAGCCGTCTAAAGC CPK28 mutagenesis 
F344Erc - GCTTTAGACGGCTGTATCTCACttcTTGTCTTAAGTTGTTCAGAACTGAAATG CPK28 mutagenesis 
F353E - GAGATACAGCCGTCTAAAGCAAgaaGCTTTAAGGGCGCTTGCTAGC CPK28 mutagenesis 
F353Erc - GCTAGCAAGCGCCCTTAAAGCttcTTGCTTTAGACGGCTGTATCTC CPK28 mutagenesis 
a, underlined residues deviate from the wild-type CPK28 sequence for directed mutagenesis 
 
Table 5. Custom peptides used in this study. 
Name Sequence M.W. (Da)b Purpose 
W3 LKWKKLLKLLKKLLKLG 2063.8 Binding assays, 
kinase assays, 
native PAGE 
RG27 RILSKKGNRYSEKDAAVVVRQMLKVAG 3017.62 Native PAGE 
FA19 FIKPGKRFHDIVGSAYYVA 2168.55 Native PAGE 
RK21 RKPWATISDSAKDFVKKLLVK 2430.94 Native PAGE 
FR26 FVKKLLVKDPRARLTAAQALSHAWVR 2975.61 Native PAGE 
RR16 RARTAALQALSHAWVR 1807.11 Native PAGE 
LL22 LRQFVRYSRLKQFALRALASTL 2638.18 Native PAGE 
pLL22 LRQFVRYSRLKQFALRALA(pS)TLa 2718.18 Native PAGE 
ACSM+1 NNLRLSMGKR 1188.41 Kinase substrate 
a, phosphorylated on Ser360; b, M.W., molecular weight. 
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Figure Captions 
Figure 1. Analysis of HRP::CaM6 binding to recombinant CPKs.  A, Spot blot overlay assay of 
purified His-tagged CPKs along with negative (GST) and positive (GST-GmCaMK1) controls 
Nitrocellulose membranes were stained with Ponceau S to assess loading and the same membrane was 
probed with 200 nM HRP::CaM6 in the presence of 2 mM CaCl2.  Binding was detected as described in 
Experimental Procedures.  Two different film exposures show that only CPK28 binds substantially at 200 
nM HRP::CaM6.  Subgroups to which each CPK belong are indicated. B, Crude extracts containing His-
tagged recombinant CPKs were probed for phosphoproteins by blotting with pIMAGO.  Anti-His 
immunoblotting indicates the relative amount of each recombinant kinase.  The K91E mutant of CPK28 
is shown as a non-phosphorylated control.  All recombinant kinases were active and autophosphorylated 
in situ.  M, molecular weight marker; Gm, Glycine max; HRP; horse-radish peroxidase. 
 
Figure 2. Interaction between CPK28 and CaM is Ca2+-dependent. A, Spot blot overlay assay of 
purified His6-CPK28 probed in the presence (2 mM CaCl2) or absence (5 mM EGTA) of Ca2+, or in the 
presence of Ca2+ with addition of the high affinity CaM-binding peptide W3 (2 mM CaCl2 + W3).  B, 
Binding of CPK28 to immobilized CaM (CaM-Sepharose). 20 µg of purified His6-CPK28 was bound to 
immobilized CaM in the presence of Ca2+ (2 mM CaCl2) with (+W3) or without (-W3) the addition of the 
W3 peptide.  After washing 3 times with buffer containing 2 mM CaCl2, bound proteins were eluted in 
three fractions with buffer containing 5 mM EGTA.  Fractions were assessed by immunoblotting with 
anti-His6 antibodies. 
 
Figure 3. Kinetic analysis of the CPK28-CaM interaction by biolayer interferometry.  A, 
Wavelength shift curves for CPK28 binding to Biotin-CaM6 in the Octet system.  Biotin-CaM6 was 
immobilized on streptavidin sensors and was incubated for 30 min (1800 s) with the indicated 
concentrations of His6-CPK28 in the presence of 100 µM CaCl2. B, Determination of a dissociation 
constant for the CPK28-CaM interaction.  Requilibrium was determined for each concentration of His6-
CPK28 (black squares) and was fitted using a 1:1 binding model (black line) as described in Experimental 
Procedures.  The Kd computed from fitted data is shown (±SE).  Data in A and B are representative of 
three replicate experiments performed with independently prepared samples of recombinant CPK28. 
 
Figure 4. CaM binds to a peptide from the CPK28 junction domain.  A, Schematic map of the domain 
organization of CPK28 showing the location of peptides (magenta boxes) and recombinant proteins (blue 
boxes) used to delineate the CaM-binding domain.  B, Peptide binding by CaM6 in native PAGE in the 
presence (100 µM CaCl2) or absence (2 mM EGTA) of Ca2+ as indicated.  CaM-peptide complexes were 
visualized by staining with Gelcode Blue protein stain after electrophoresis. C, Overlay assay indicating 
lack of binding to a C-terminal fragment (V276 to A328) of the CPK28 kinase domain.  Proteins were 
spotted to nitrocellulose membrane and probed with 200 nM HRP::CaM6.  Full length CPK28 was 
detected by HRP::CaM6 but the V276-A328 fragment was not. D, Helical model of the LL22 peptide 
rendered in PyMol.  Basic residues are shown in blue and hydrophobic residues are shown in orange.  
Basic and hydrophobic faces of the amphipathic helix are indicated (above and below the dashed line, 
respectively). Potential hydrophobic anchor residues are indicated. E, HRP::CaM6 overlay analysis of 
CaM-binding to CPK28 CaMBD mutants.  Approximately 400 ng of each protein was spotted and the 
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blot was probed with 100 nM HRP::CaM6. CaMBD, CaM-binding domain; HRP, horse-radish 
peroxidase. F, Clustal-Omega alignment of the CPK28 CaM-binding domain with the corresponding 
region from other species.  The CaM-binding domain is highly conserved across diverse plant taxa.  
Genbank accession numbers for sequences used for the alignment are: Arabidopsis lyrata, 
XP_002865081.1; Brassica napus, XP_013653730.1; Capsela rubella, XP_006282144.1; Medicago 
truncatula, XP_003612167.1; Glycine max, XP_003538879.1; Oryza sativa, NP_001059444.1; Zea mays, 
NP_001151048.1; Brachypodium distachyon, XP_003557300.1; Physcomitrella patens, 
XP_001766209.1. 
 
Figure 5. CaM inhibits Ca2+-activated autophosphorylation and transphosphorylation of fully 
dephosphorylated CPK28.  A, Time-dependent autophosphorylation of fully dephosphorylated His6-
CPK28.  A single reaction was initiated by the addition of ATP and was sampled at the time points 
indicated. A reaction lacking ATP was included as a control.  Samples were assessed by blotting with the 
pIMAGO reagent or with anti-phosphothreonine (anti-pThr) antibodies.  Approximately 500 ng of protein 
was loaded in each lane.  B, Effect of Ca2+ and Ca2+/CaM on autophosphorylation of CPK28.  Reactions 
were prepared as indicated, initiated by the addition of ATP and allowed to proceed for 30 s.  Samples 
were assessed by blotting with the pIMAGO reagent and a CBBG250-stained membrane is shown to 
demonstrate equal loading (~500 ng) for each sample. C, Effect of Ca2+ and Ca2+/CaM on CPK28 peptide 
kinase activity.  CPK28 activity towards the ACSM+1 peptide (10 µM) was assessed in the absence 
(EGTA) or presence (calcium) of 100 µM CaCl2 with or without the addition of 1 µM CaM6 as indicated. 
Values reported are CPK28 activity relative to the Ca2+-activated state. D, The W3 peptide blocks 
Ca2+/CaM inhibition of CPK28 peptide kinase activity.  Activity of Ca2+-activated CPK28 was assessed in 
the absence (- W3) or presence (+ W3) of 2 µM W3 peptide, with or without the addition of 1 µM CaM6 
as indicated.  Specific activities under each condition tested are shown (inset).  Point estimates in C and D 
represent mean with standard deviation of three technical replicates.  Data shown are representative of at 
least two independent preparations of recombinant CPK28. IB, immunoblot; CBBG250, Coomassie 
Brilliant Blue G250. 
 
Figure 6. Ca2+/CaM-inhibition of wild-type CPK28 and the F344E mutant. Representative 
determinations of the IC50 for Ca2+/CaM inhibition of A, CPK28 or B, the F344E mutant.  Assays were 
performed at 100 µM CaCl2, 100 µM ATP and 10 µM ACSM+1 peptide.  CaM inhibition is shown on a 
relative scale where 100% inhibition corresponds to an approximately 60% loss of activity compared to 
untreated protein. 
 
Figure 7. Production of differentially phosphorylated forms of CPK28 during recombinant protein 
production.  Proteins were expressed under three different conditions as described in Experimental 
procedures.  Autophosphorylation status of each phosphoform (P-, P+, P++) was assessed by blotting with 
pIMAGO and, anti-pThr and anti-pTyr antibodies as indicated.  The K91E kinase-dead mutant is shown 
as a non-phosphorylated control.  Approximately 500 ng of protein was loaded in each lane.  IB: 
immunoblot; CBBG250, Coomassie Brilliant Blue G250. 
 
Figure 8. Autophosphorylation enhances basal levels, Ca2+-responsiveness, and Ca2+/CaM 
sensitivity of CPK28 peptide kinase activity.  A, Peptide kinase activity of the three different CPK28 
phosphoforms toward the ACSM+1 peptide substrate (10 µM).  Activity was measured in the presence of 
500 µM EGTA, 100 µM CaCl2 or no treatment (Untreated).  Activities are reported relative to Ca2+-
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stimulated P--CPK28.  B, Analysis of P-- and P+-CPK28 peptide kinase activity across a range of free Ca2+ 
concentrations. Open circles, P+-CPK28; closed circles, P--CPK28.  Grey region represents the 
physiological range of free Ca2+ in plants (approximately 100 nM to 1000 nM); inset, Fold activation of P-
-CPK28 and P+-CPK28 by Ca2+ across the physiological range.  Fold-activation was calculated relative to 
the activity at 100 nM free Ca2+.  Point estimates are mean with 95% confidence intervals.  C, Peptide 
kinase activity of the three different CPK28 phosphoforms in the presence of 100 µM CaCl2 with or 
without (untreated) the addition of 1 µM CaM6.  For each phosphoform, activity is reported relative to the 
untreated control.  Point estimates in A and C represent means with standard deviation of three technical 
replicates.  Data shown are representative of at least two independent preparations of recombinant 
CPK28. 
 
Figure 9. Effect of Ser360 autophosphorylation on CaM-binding to CPK28.  A, Product ion spectrum 
identifying Ser360 within the CPK28 CaM-binding domain as an autophosphorylation site. B, 
HRP::CaM6 binding to the three CPK28 phosphoforms.  Approximately 400 ng of each protein was 
spotted and the blot was probed with 100 nM HRP::CaM6 in the presence of calcium (2 mM).  C, 
HRP::CaM6 binding for phospho-CPK28 and S360A mutants.  Approximately 400 ng of each protein 
was spotted and the blot was probed with 100 nM HRP::CaM6. D, Native PAGE analysis of CaM-
binding to the LL22 peptide and its phosphorylated variant (pLL22).  A near-complete mobility shift of 
CaM required more pLL22 peptide compared to the dephosphorylated form. CaM (240 pmol) was 
incubated with different amounts of peptide in the ratios indicated in a 20 µl reaction for 60 min prior to 
electrophoresis.  HRP, horse-radish peroxidase 
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